LoginSign Up
Opentrons

Opentrons

A company building robots to automate experiments of life scientists

In March 2018, Opentrons announced the launch of its newest lab robot, OT-2 and new no-code Protocol Designer. The OT-2 release is supported by the close of a $10M seed funding round, led by Khosla Ventures with participation from Lerer Hippeau Ventures, Y Combinator Continuity Fund, and Jeff Kindler, former CEO of Pfizer. This launch and financial backing furthers Opentrons' mission to bring affordable automation to any biologist.

Founded out of Brooklyn in 2013, Opentrons's stated goal is to save researchers from having to carry out repetitive tasks.

Timeline

People

Name
Role
Related Golden topics

Chiu Chau

Co-founder, CTO

Jonathan Badal

CEO

Will Canine

Co-founder, CPO

Further reading

Title
Author
Link
Type

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References